Resistance to Selective FGFR Inhibitors in <i>FGFR-</i> Driven Urothelial Cancer
Francesco Facchinetti(Inserm), Luc Friboulet(Inserm)
Cited by 69
Related Papers
The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer
|Cancer Discovery|2014|842
Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
|Lung Cancer Targets and Therapy|2017|53
Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
|BMC Cancer|2010|24
The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib
|npj Precision Oncology|2026|0